ASPG and lymphoma: The aim of this study was to evaluate the response rate, progression-free survival (PFS), and survival time (ST) in a new chemotherapeutic protocol (LHOP protocol) using l-asparaginase in place of cyclophosphamide in the traditional CHOP protocol for the treatment of canine multicentric lymphoma.